-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Outperform on Boston Scientific, Raises Price Target to $51

Benzinga·10/29/2026 11:12:41
Listen to the news
Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $50 to $51.